News

Pharmaceutical Technology34m
FDA approves Akeso’s monoclonal antibody for nasopharyngeal carcinoma
The FDA has granted approval to Akeso's differentiated programmed cell death protein 1 (PD-1) monoclonal antibody, penpulimab ...
Agence France-Presse30m
Incyte to Highlight Early-Stage Oncology Data at American Association for Cancer Research Annual Meeting 2025
Incyte (Nasdaq:INCY) today announced that the Company will present new early-stage data from its oncology portfolio at the American Association of Cancer Research (AACR) Annual Meeting 2025 in Chicago ...